Regulation of adrenoceptors and muscarinic receptors in the heart

General Physiology and Biophysics

Volumn 22, Issue 1, 2003, Pages 3-14

  Myslivecek J ^a   Trojan, Stanislav ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adrenoceptors; Heart; Heterologous regulation; Homologous regulation; Muscarinic receptors

Indexed keywords

ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; HEART RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR; RECEPTOR SUBTYPE;

HEART; HEART FUNCTION; HEART MUSCLE CELL; HOMEOSTASIS; HUMAN; NEUROTRANSMISSION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SHORT SURVEY;

ANIMALS; HEART; HEMOSTASIS; HOMEOSTASIS; HORMONES; HUMANS; ION CHANNEL GATING; MYOCARDIUM; NEUROPEPTIDES; RECEPTORS, ADRENERGIC; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION;

EID: 0038204291     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (38)

1. Brodde O. E., Michel M. C. (1999): Adrenergic and muscarinic receptors in the human heart. Pharmacol. Rev. 51, 651-688
2. Bünemann M., Lee K. B., Pals-Rylaarsdam R., Roseberry A. G., Hosey M. M. (1999): Desensitization of G-protein-coupled receptors in the cardiovascular system. Annu. Rev. Physiol. 61, 169-192
3. Colecraft H. M., Egamino J. P., Sharma V. K., Sheu S. S. (1998): Signaling mechanisms underlying muscarinic receptor-mediated increase in contraction rate in cultured heart cells. J. Biol. Chem. 273, 32158-32166
4. Collins S., Caron M. G., Lefkowitz R. J. (1991): Regulation of adrenergic receptor responsiveness through modulation of receptor gene expression. Annu. Rev. Physiol. 53, 497-508
5. Cordeaux Y., Hill S. J. (2002): Mechanisms of cross-talk between G-protein-coupled receptors. Neurosignals 11, 45-57
6. Dhein S., van Koppen C. J., Brodde O. E. (2001): Muscarinic receptors in the mammalian heart. Pharmacol. Res. 44, 161-182
7. Disatnik M. H., Shainberg A. (1992): Effects of calcium and calcium-channel blocker methoxyverapamil on the β-adrenoceptors in myocardial cells in vitro. Biochem. Pharmacol. 43, 213-217
8. Ferguson S. S., Zhang J., Barak J. S., Caron M. G. (1997): Pleiotropic role for GRKS and β-arrestins in receptor regulation. News Physiol. Sci. 12, 145-151
9. Garofolo M. C., Seidler J. F., Auman J. T., Slotkin T. A. (2002): β-adrenergic modulation of muscarinic cholinergic receptor expression and function in developing heart. Am. J. Physiol. - Regul. Integr. C. 282, R1356-1363
10. 3-adrenoceptors in the cardiovascular system. Trends Pharmacol. Sci. 21, 426-431
11. 1-adrenergic receptor. Am. J. Physiol. - Endocrinol. Met. 280, E199-202
12. Hamilton S. E., Hardouin S. N., Anagnostaras S. G., Murphy V. C., Richmond K. N., Silva A. J., Feigl E. O., Nathanson N. M. (2001): Alteration of cardiovascular and neuronal function in M1 knockout mice. Life Sci. 68, 2489-2493
13. 1 angiotensin receptor internalization. Regul. Pept. 91, 29-44.
14. Hur E. M., Kim K. T. (2002): G protein-coupled receptor signalling and cross-talk. Achieving rapidity and specificity. Cell. Signal. 14, 397-405
15. Jackson D. A., Nathanson N. M. (1995): Subtype-specific regulation of muscarinic receptor expression and function by heterologous receptor activation. J. Biol. Chem. 270, 22374-22377
16. Kaumann A. J., Molenaar P. (1997): Modulation of human cardiac function through 4 β-adrenoceptor populations. Naunyn-Schmiedeberg's Arch. Pharmacol. 355, 667-681
17. Klangakalya B., Chan A. (1988): Structure-activity relationships of steroid hormones on muscarinic receptor binding. J. Steroid Biochem. 29, 111-118
18. 2-adrenergic receptors. cAMP and the third intracellular loop of m1 muscarinic receptors confer heterologous regulation. J. Biol. Chem. 268, 7949-7957
19. 1 receptors. Biochem. Biophys. Res. Commun. 129, 699-704
20. 2-adrenoceptors but does not transregulate muscarinic cholinoceptors in rat heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 353, 213-225
21. Minton A. P., Sokolovsky M. (1990): A model for the interaction of muscarinic receptors, agonists, and two distinct effector substances. Biochemistry 29, 1586-1593.
22. Mizuki T., Kobayashi H., Nakashima Y., Kuroiwa A., Izumi F. (1994): Lidocaine increases the number of β-adrenoreceptors in neonatal rat cardiocytes in culture. Naunyn-Schmiedeberg's Arch. Pharmacol. 349, 170-174
23. Morris A. J., Malbon C. C. (1999): Physiological regulation of G protein-linked signaling. Physiol. Rev. 79, 1373-1430
24. Mysliveček, J., Tuček S. (2002): Plasticity of cardiac adrenergic and muscarinic receptors under hydrocortisone. J. Physiol. (Paris) 96, 152-153
25. Mysliveček J., Trojan S., Tuček S. (1996): Biphasic changes of muscarinic and β-adrenergic receptors in rat heart atria during DFP treatment. Life Sci. 58, 2423-2430
26. Mysliveček J., Lisá V., Trojan S., Tuček S. (1998): Heterologous regulation of muscarinic and beta-adrenergic receptors in rat cardiomyocytes in culture. Life Sci. 63, 1169-1182
27. Nomura Y., Kajiyama H., Segawa T. (1982): Alteration in sensitivity to isoproterenol and acetylcholine in the rat heart after repeated administration of isoproterenol. J. Pharmacol. Exp. Ther. 220, 411-416
28. Paraschos A., Karliner J. S. (1994): Receptor crosstalk: effects of prolonged carbachol exposure on beta 1-adrenoceptors and adenylyl cyclase activity in neonatal rat ventricular myocytes. Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 267-276
29. Reithmann C., Werdan K. (1995): Chronic muscarinic cholinoceptor stimulation increases adenylyl cyclase responsiveness in rat cardiomyocytes by a decrease in the level of inhibitory G-protein alpha-subunits. Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 27-34
30. Reithmann C., Panzner B., Werdan K. (1992): Distinct pathways for beta-adrenoceptor-induced up-regulation of muscarinic acetylcholine receptors and inhibitory G-protein alpha-subunits in chicken cardiomyocytes. Naunyn-Schmiedeberg's Arch. Pharmacol. 345, 530-540
31. Rosenberger L. B., Yamamura H. I., Roeske W. R. (1980): The regulation of cardiac muscarinic cholinergic receptors by isoproterenol. Eur. J. Pharmacol. 65, 129-130
32. Rousell J., Haddad E. B., Mak J. C., Webb B. L., Giembycz M. A., Barnes P. J. (1996): β-adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5′-monophosphate-dependent protein kinase and protein kinase C. Mol. Pharmacol. 49, 629-635
33. Selbie L. A., Hill S. J. (1998): G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signaling pathways. Trends Pharmacol. Sci. 19, 87-93
34. Tsao P., Cao T., von Zastrow M. (2001): Role of endocytosis inmediating downregulation of G-protein-coupled receptors. Trends Pharmacol. Sci. 22, 91-96
35. Tseng Y. T., Stabila, J. P., Nguyen T. T., McGonnigal B. G., Waschek J. A., Padbury J. F. (2001): A novel glucocorticoid regulatory unit mediates the hormone responsiveness of the beta1-adrenergic receptor gene. Mol. Cell. Endocrinol. 181, 165-178
36. Waisberg M., Shainberg A. (1992): Characterization of muscarinic cholinergic receptors in intact myocardial cells in vitro. Biochem. Pharmacol. 43, 2327-2334
37. Watanabe A. M., McConnaughey M. M., Strawbridge R. A., Fleming J. W., Jones L. R., Besch H. R. (1978): Muscarinic cholinergic receptor modulation of β-adrenergic receptor affinity for catecholamines. J. Biol. Chem. 253, 4833-4836
38. Zimmer H. G. (1997): Catecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression. J. Mol. Med. 75, 849-859